BeOne Medicines ONC
NASDAQ ONC
$357.81 -4.87 (-1.34%)
As of: Sep 4, 2026 · 3:17 PM EDT

BeOne Medicines (ONC) Equity Income (2020 - 2023)

Analysis

BeOne Medicines (ONC) Equity Income (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn -
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn -
8 Royalty Pharma 28.43 Bn 27.59 Bn - 4.08 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
10 Incyte 25.59 Bn 21.05 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -3.95 Mn
Sep 30, 2023 -2.68 Mn
Jun 30, 2023 -2.48 Mn
Mar 31, 2023 -169,000.00
Dec 31, 2022 -5.58 Mn
Sep 30, 2022 -2.95 Mn
Jun 30, 2022 -5.91 Mn
Mar 31, 2022 -16.97 Mn
Dec 31, 2021 -9.53 Mn
Sep 30, 2021 23.76 Mn
Jun 30, 2021 -2.33 Mn
Mar 31, 2021 -3.33 Mn
Dec 31, 2020 1.85 Mn
Sep 30, 2020 -1.05 Mn
Jun 30, 2020 4.30 Mn
Mar 31, 2020 6.96 Mn